Xiid Launches Elite Advisory Board, Enlists Rachel Higham to Help Drive Next Phase of Growth
Xiid Corp., which is revolutionizing cyber defense with zero knowledge networking, today announced it has assembled a distinguished advisory board and added Rachel Higham to this circle of trusted advisors. Formerly Marks & Spencer’s chief digital and technology officer, Higham will serve as a special advisor and consultant, leading Xiid’s go-to-market strategy with hyperscalers, colocation companies and telecom services providers.
“Rachel contributes valuable perspective and experience,” said Xiid CEO Steve Visconti. “Now the new Xiid Advisory Board – which already includes global industry leaders with deep roots at such companies as Alcatel, Capgemini, Deloitte, Microsoft and Vodafone – is even stronger.”
Higham learned of Xiid’s unique approach during her time with Marks & Spencer. In addition to her experience with the multinational retailer, she served as WPP’s CIO, BT’s managing director of IT and MD Asia and Vodafone’s head of cloud and infrastructure centre of excellence.
“Xiid fortifies companies against threats such as ransomware in a way that no other solution can,” said Higham. “Having experienced Xiid’s unrivaled approach firsthand, I am thrilled by the opportunity to share it with other organizations. During recovery from a destructive cyberattack, it is often difficult to maintain a secure perimeter as you restore critical systems and integrations. Xiid's secure tunnelling technology makes that incredibly simple, increasing speed to recovery and reducing both risk and costs.”
The Xiid Advisory Board brings together an impressive group of top global executives with board-level experience across the telecom, finance, and defense sectors. These power players have led multi-billion-dollar technology, security, and transformation initiatives.
“Xiid is redefining how secure connectivity is designed – not as an add-on, but as a foundation of modern enterprise architecture,” said Xiid Advisory Board Member Albert Hitchcock. “I’m excited to contribute to Xiid’s mission to make organizations stronger and more resilient.”
Hitchcock is a global technology leader recognized for large-scale IT transformation and cloud innovation, having served as a CIO at Vodafone. Xiid Advisory Board member Bertrand Alexis contributes more than 25 years’ experience supporting growing international companies. Jérôme Desbonnet is a C-level cybersecurity and cloud leader at Capgemini. Kathryn Dougherty is an advisor on cyber frameworks and regulatory alignment. Formerly CEO at Alcatel-Lucent RT and vice president-cybersecurity at Capgemini, Serge Dujardin adds advisory board member to his title at Xiid, where he serves as general manager and executive vice president-international. Michel Emelianoff, formerly CEO of Alcatel-Lucent Enterprise, is a specialist in enterprise networking, cloud, and IoT systems.
Andy MacLeod, who has held C-level roles at Verizon and Vodafone, brings expertise in global telecom and infrastructure. Kathryn Mihalich is a specialist in compliance strategy, data governance, and security architecture. Ericsson leader Ola Persson is a telecom and 5G infrastructure expert focusing on large-scale network design and operations. Anna Vikström Persson is a leadership and culture transformation specialist for multinational organizations, having served in that function for such companies as Ericsson and Sandvik. A former senior partner and vice chair for Deloitte UK, William Touche is a specialist in board governance, financial systems, and leadership transformation. A former Houghton Mifflin Harcourt CEO who has served as a vice president at Microsoft, Oracle and PeopleSoft, Linda Zecher is a renowned executive with deep expertise in digital transformation, the public sector, and enterprise growth.
“Our advisory board brings together technology leaders who have shaped the world’s largest enterprises,” said Visconti. “Their commitment adds to Xiid’s strength as we navigate strategic expansion, ensure product-market fit and accelerate enterprise adoption on our zero knowledge networking mission to help organizations achieve true prevention by design.”
About Xiid
Xiid is revolutionizing cybersecurity with its zero knowledge networking (ZKN) architecture, which powers Xiid Identity and Access Management and Xiid SealedTunnel. Xiid’s ZKN architecture goes beyond zero trust, empowering organizations to shift from reacting to attacks to eliminating the attack surface altogether. For more information about Xiid and how its unprecedented security can make you stronger, visit www.xiid.com and follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251105683579/en/
Contacts
Media Contact
Emily Roberts
PRforXiid@bospar.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy5.11.2025 14:00:00 EET | Press release
Registrar Corp, a global leader in regulatory compliance and technology solutions and a Paine Schwartz Partners portfolio company, today announced the acquisition of CMC Medical Devices (CMC), a Spain-based provider of medical device regulatory, clinical, and compliance consulting services. The combination of Registrar Corp’s global network and CMC’s clinical and technical expertise creates a unified partner to help medical device and in vitro diagnostic (IVD) manufacturers bring products to market faster and with greater confidence. “We’re proud to welcome CMC Medical Devices to the Registrar Corp family,” said Raj Shah, CEO of Registrar Corp. “Together, we offer medical device manufacturers a single partner to navigate complex regulations and access the U.S., EU, and other key global markets—so they can focus on innovation rather than compliance.” “Joining Registrar Corp enables us to deliver even greater value to our clients,” said Manuel Mateos, CEO of CMC Medical Devices. “Our sha
Macrobond Selected by T. Rowe Price to Support Evolving Research and Investment Workflows5.11.2025 14:00:00 EET | Press release
Macrobond, the global platform for macroeconomic and financial data, has been selected by T. Rowe Price to support the continued evolution of its cross-asset research and systematic strategy workflows. As financial institutions look to strengthen data-driven decision-making, the need for scalable technology and integrated platforms has never been more critical. T. Rowe Price’s decision to implement Macrobond reflects a broader commitment to enhancing research workflows with modern, flexible solutions built for the pace and complexity of today’s investment landscape. Meeting the Demands of a Dynamic Environment The ability to integrate complex data sets, streamline analysis, and support automation were key factors in the selection process. Macrobond’s API and flexible data infrastructure provided a strong foundation for collaboration. “T. Rowe Price is continually investing in technology to improve the efficiency and quality of our research processes,” said Tae Kim, Head of Fixed Income
Cybersecurity Leader Armis Closes $435 Million Round at $6.1 Billion Valuation5.11.2025 14:00:00 EET | Press release
Armis, the cyber exposure management and security company, today announced a pre-IPO funding round of $435 million, bringing the company’s valuation to $6.1 billion. The round was led by Growth Equity at Goldman Sachs Alternatives with major participation from CapitalG, and was joined by new investor Evolution Equity Partners, alongside several existing investors. The investment round comes amid continued growth, with the company recently surpassing $300 million in Annual Recurring Revenue (ARR), growing over 50%. Armis has worked with over 40% of the Fortune 100, including 7 of the Fortune 10, and helps protect leading organizations around the globe, including manufacturers, airlines, financial services firms, healthcare institutions, and state and federal agencies. Yevgeny Dibrov, CEO and Co-Founder of Armis: “This round marks another defining moment in our journey to build a category-defining cybersecurity company. Our growth proves that organizations are embracing a unified, exposu
Compass Pathways to Participate in Stifel 2025 Healthcare Conference5.11.2025 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the Stifel 2025 Healthcare Conference in New York, NY at 10:40 am ET on Tuesday, November 11, 2025. A live audio webcast of these events will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP36
Watchmaker Genomics Launches TAPS+, Expanding Multimodal Capabilities in Oncology Ahead of AMP 20255.11.2025 13:00:00 EET | Press release
Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule. By capturing multiple biological dimensions in a single assay, TAPS+ delivers a richer, more comprehensive view of tumor biology, with the power to advance applications in translational oncology, early cancer detection, therapy response monitoring, fragmentomics, and minimal residual disease assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251105264633/en/ Watchmaker Genomics launches TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule. Key features of the TAPS+ chemistry Traditional methylation analysis techniques, such as bisulfite treatment, effectively collapse sequence diversity from four bases to three while often damaging DNA. TAPS+ overcomes these limitations with a positive-readout chemistry that
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom